- Home
- QVCGA vs TENX Comparison
QVCGA vs TENX Comparison
Compare QVCGA & TENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QVCGA
- TENX
- Stock Information
- Founded
- QVCGA 1991
- TENX 1967
- Country
- QVCGA United States
- TENX United States
- Employees
- QVCGA N/A
- TENX N/A
- Industry
- QVCGA
- TENX Biotechnology: Pharmaceutical Preparations
- Sector
- QVCGA
- TENX Health Care
- Exchange
- QVCGA NYSE
- TENX Nasdaq
- Market Cap
- QVCGA 26.1M
- TENX 21.6M
- IPO Year
- QVCGA N/A
- TENX N/A
- Fundamental
- Price
- QVCGA $3.07
- TENX $5.81
- Analyst Decision
- QVCGA
- TENX Strong Buy
- Analyst Count
- QVCGA 0
- TENX 3
- Target Price
- QVCGA N/A
- TENX $16.00
- AVG Volume (30 Days)
- QVCGA 194.0K
- TENX 42.0K
- Earning Date
- QVCGA 08-07-2025
- TENX 08-12-2025
- Dividend Yield
- QVCGA N/A
- TENX N/A
- EPS Growth
- QVCGA N/A
- TENX N/A
- EPS
- QVCGA N/A
- TENX N/A
- Revenue
- QVCGA $9,800,000,000.00
- TENX N/A
- Revenue This Year
- QVCGA $2.89
- TENX N/A
- Revenue Next Year
- QVCGA $0.45
- TENX N/A
- P/E Ratio
- QVCGA N/A
- TENX N/A
- Revenue Growth
- QVCGA N/A
- TENX N/A
- 52 Week Low
- QVCGA $2.27
- TENX $2.80
- 52 Week High
- QVCGA $39.74
- TENX $7.89
- Technical
- Relative Strength Index (RSI)
- QVCGA N/A
- TENX 49.28
- Support Level
- QVCGA N/A
- TENX $5.66
- Resistance Level
- QVCGA N/A
- TENX $6.00
- Average True Range (ATR)
- QVCGA 0.00
- TENX 0.53
- MACD
- QVCGA 0.00
- TENX -0.01
- Stochastic Oscillator
- QVCGA 0.00
- TENX 33.33
About QVCGA QVC GROUP INC
QVC Group Inc is a live social shopping company with six retail brands QVC, HSN, Ballard Designs, Frontgate, Garnet Hill, Grandin Road, and other minority interests. QVC offers assortment of ,quality merchandise and classifies its products into six groups: home, apparel, beauty, accessories, electronics and jewelry. The company has three reportable segments: QxH, QVC International, and CBI. Majority of revenue is from Home products, from QxH segment. Company also operates in Japan, Germany and Other foreign countries.
About TENX Tenax Therapeutics Inc.
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.